Tissue hypoxia during bacterial sepsis is attenuated by PR-39, an antibacterial peptide

Advances in Experimental Medicine and Biology

Volumn 530, Issue , 2003, Pages 645-652

  James, Philip E ^a   Madhani, Melanie ^b   Ross, Chris ^c   Klei, Linda ^b   Barchowsky, Aaron ^b   Swartz, Harold M ^b  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

^c KANSAS STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBACTERIAL PEPTIDE; ANTIINFECTIVE AGENT; ENDOTOXIN; HEMOGLOBIN; LIPOPOLYSACCHARIDE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PR 39; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; SUPEROXIDE; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANIMAL TISSUE; BACTERIAL CELL WALL; BLOOD PRESSURE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFICACY; ELECTRON SPIN RESONANCE; ERYTHROCYTE; GRAM NEGATIVE BACTERIUM; HEART RATE; HYPOXEMIA; KIDNEY NECROSIS; LIVER ISCHEMIA; LIVER NECROSIS; MALE; MEASUREMENT; MOUSE; NONHUMAN; OXIMETRY; OXYGEN TENSION; PRIORITY JOURNAL; SEPSIS; SEPTIC SHOCK; TISSUE NECROSIS;

ANIMALIA; BACTERIA (MICROORGANISMS); NEGIBACTERIA;

EID: 0242267151     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4615-0075-9_64     Document Type: Conference Paper

References (14)

1. Cobb, J.P. and Danner, R.L. Nitric oxide and septic shock. JAMA 1996;275:1192-1196.
2. Wright, C.E., Rees, D.D. and Moncada, S. Protective and pathological roles of nitric oxide in endotoxic shock. Cariovascular Research 1992; 26:48-57.
3. Nathan, C.F., Stuehr, D.J. Does endothelium-derived nitric oxide have a role in cytokine-induced hypotension? J Natl Cancer Inst 1990;82:726-728.
4. Nathan, C., Xie, Q-W. Nitric oxide synthases: roles, tolls, controls. Cell 1994;78:915-918.
5. Di Silvio, M., Nussler, A.K., Geller, D.A., and Billiar, T.R. A role for nitric oxide in liver inflammation and infection. In:Nitric Oxide: Principles and Actions (Lancaster, J. Jr., ed), Academic Press, 1996; 219-236.
6. Agerbeth, B., Lee, J., Bergman, T., Carlquist, M., Boman, H. G., Mutt, V., and Jomvall, H.: Amino acid sequence of PR39 - Isolation from pig intestine of a new member of the family of proline-argine-rich antibacterial peptides. European Journal Biochemistry. 1991;202: 849-854.
7. Shi, J., Ross, C.R., Chengappa, M.M., and Blecha, F. Identification of a proline-rich antibacterial peptide from neutrophils that is analogous to PR-39, and antibacterial peptide from the small intestine. J Leukocyte Biol 1994; 56:807-811.
8. Boman, H. G., Agerbeth, B., and Boman, A.: Mechanism of action on Escherichia coli of cecropin P1 and PR39, two antibacterial peptides from pig intestine. Infection and Immunity. Biochemical and Biophysical research communication. 1993;61:29782984.
9. Shi, J., Ross, C. R, Leto, T. L, and Blecha, F.: PR29, a proline-rich antibacterial peptide that inhibits phagocyte NADPH oxidase activity by binding to Src homolgy 3 domains of p47phox. Preoceedings National Academy of Science, USA. 1996; 93:6014-6018.
10. Huang, H., Ross, C. R, and Blecha, F.: Chemoattractant properties of PR39, a neutrophil antibacterial peptide. Journal of Leukocytes Biology 1997;61:624-628.
11. Gallo, R. L, Ono, M., Povsic, T., Page, C., Eriksson, E.: Syndecans, cell surface heparan sulfate proteoglycans, are induced by a proline-rich antibacterial peptide from wounds. Proceedings National Academy of Science, USA 1994;91:11035-11039.
12. Korthuis, R.J., Gute, D.C., Blecha, F., Ross, C.R. Pr-39, a proline/arginine-rich antimicrobial peptide, prevents postischemic microvascular dysfunction. Am J Physiol 1999;277:H1007-H1013.
13. James, P.E., Grinberg, O.Y., Goda, F., O'Hara, J.A., and Swartz, H.M. Gloxy: an oxygen-sensitive coal for accurate measurement of low oxygen tensionis in biological systems. Mag Res Med 1997; 38:48-58.
14. 2 from tissue by in vivo EPR. Nitric oxide; Chemistry and Biology 1999; 3:292-301.